“To whom it may concern, I worked with Robert on one of the top corporate priority R&D projects at Angiotech, the Quill Self Retaining Suture System. During roughly one and a half years Robert led the team to the approval and launch of two major product brands, as well as the reinitiation of a manufacturing line which has been previously unable to attain acceptably low rejection rates for years. In addition, Roberts leadership guided the team to create significant innovation truly reinventing the suture system, resulting in over 10 new patent applications. Robert is a natural leader and an excellent manager. He focuses well on the goals of the project and the company, while balancing with the individual needs of his team and direct reports. It was always a pleasure to work with Robert and he was highly regarded by both his peers and the executive team at Angiotech. It is my pleasure to recommend Robert in the highest regard.”
Washington, District of Columbia, United States
Contact Info
526 followers
500+ connections
About
Activity
-
At Viva Technology in Paris, Dr. Ansgar Resch, Vice President of Abbott's Diabetes Care, opened the workshop with his keynote on The Superpower of…
At Viva Technology in Paris, Dr. Ansgar Resch, Vice President of Abbott's Diabetes Care, opened the workshop with his keynote on The Superpower of…
Liked by Robert A. Herrmann
-
MCRA is pleased to announce its role in the successful granting of Darmiyan’s De Novo request for BrainSee by the U.S. Food and Drug Administration…
MCRA is pleased to announce its role in the successful granting of Darmiyan’s De Novo request for BrainSee by the U.S. Food and Drug Administration…
Liked by Robert A. Herrmann
Experience & Education
Patents
-
Medical Devices having porous component for controlled diffusion
Issued US 8388678
According to an aspect of the present invention, implantable or insertable medical devices are provided which contain the following: (a) substrate having one or more depressions that contain at least one therapeutic agent and (b) a porous membrane disposed over the substrate and the one or more depressions, which regulate transport of chemical species between the therapeutic-agent-containing depressions and the exterior of the device. The substrate and the porous membrane are formed of…
According to an aspect of the present invention, implantable or insertable medical devices are provided which contain the following: (a) substrate having one or more depressions that contain at least one therapeutic agent and (b) a porous membrane disposed over the substrate and the one or more depressions, which regulate transport of chemical species between the therapeutic-agent-containing depressions and the exterior of the device. The substrate and the porous membrane are formed of different materials each with a different thermal expansion coefficient. Moreover, one of the substrate and the porous membrane at least partially surrounds the other. Other aspects of the present invention are directed to methods of making such medical devices, and methods of treatment using such medical devices.
-
BIDIRECTIONAL SELF-RETAINING SUTURES WITH LASER-MARKED AND/OR NON-LASER MARKED INDICIA AND METHODS
Issued EU WO2011090628 (A2)
The present invention relates to a marked heterofunctional suture thread has two or more sections having different features. One or more sections of the suture thread are provided with laser-marked and non-laser marked indicia in order that they may be identified and differentiated from other sections. The suture thread may have retainers on the surface of one or more sections such that the suture thread can engage and retain tissue without knots. The markers may be used to indicate fixed…
The present invention relates to a marked heterofunctional suture thread has two or more sections having different features. One or more sections of the suture thread are provided with laser-marked and non-laser marked indicia in order that they may be identified and differentiated from other sections. The suture thread may have retainers on the surface of one or more sections such that the suture thread can engage and retain tissue without knots. The markers may be used to indicate fixed features of a section of suture thread such as the presence and/orientation of retainers. In particular embodiments, laser-marked and non-laser marked indicia are used to identify the transition section of a bidirectional self-retaining suture.
Other inventorsSee patent -
METHOD AND APPARATUS FOR ELEVATING RETAINERS ON SELF-RETAINING SUTURES
Issued EU WO2009105663 (A2)
The present invention relates to a method and device to elevate retainers on a suture thread to a desired angle such that the retainers can retain the desired elevation. The retainers can be elevated using an apparatus having at least one roller and at least one bending bar, wherein the bending bar contacts the retainers adjacent to the at least one roller to apply a force to the retainers. The retainers can also be elevated using a tube-shaped apparatus which allows the retainers on a suture…
The present invention relates to a method and device to elevate retainers on a suture thread to a desired angle such that the retainers can retain the desired elevation. The retainers can be elevated using an apparatus having at least one roller and at least one bending bar, wherein the bending bar contacts the retainers adjacent to the at least one roller to apply a force to the retainers. The retainers can also be elevated using a tube-shaped apparatus which allows the retainers on a suture thread to be bent by the inner surface of the tube-shaped apparatus. In various embodiments of the invention, a suture can be made up of an inner core and a coating that upon a stimuli increases the protrusion of the retainers away from the suture core thereby ensuring that the suture is held securely in place, preventing wound separation and dehiscence.; In an embodiment of the invention, the application of the coating to the outer face of the retainer and attractive forces between the coating at different points results in the distension of the retainers away from the suture core. In an alternative embodiment of the invention, the coating inserts into the cut associated with the retainer and repulsive or expansive forces result in a pushing out of the cut and thereby the distending of the retainers away from the suture core.
Other inventorsSee patent
Recommendations received
1 person has recommended Robert A.
Join now to viewMore activity by Robert A.
-
Another successful #LSIUSA24 conference in the books! We had an amazing week meeting with hundreds of innovators, investors and partners. Next stop…
Another successful #LSIUSA24 conference in the books! We had an amazing week meeting with hundreds of innovators, investors and partners. Next stop…
Liked by Robert A. Herrmann
-
MCRA is pleased to announce its role in the successful Premarket Approval (PMA) application decision by the U.S. Food and Drug Administration (FDA)…
MCRA is pleased to announce its role in the successful Premarket Approval (PMA) application decision by the U.S. Food and Drug Administration (FDA)…
Liked by Robert A. Herrmann
-
We are excited to see the 3-year results of the CE mark study published in the European Journal of Cardio-Thoracic Surgery! https://lnkd.in/e-weF82c…
We are excited to see the 3-year results of the CE mark study published in the European Journal of Cardio-Thoracic Surgery! https://lnkd.in/e-weF82c…
Liked by Robert A. Herrmann
-
Understanding how your technology is positioned in the market is critical to its success. MCRA’s team of experts analyze existing data or design and…
Understanding how your technology is positioned in the market is critical to its success. MCRA’s team of experts analyze existing data or design and…
Liked by Robert A. Herrmann
-
As if meeting with us wasn’t a good enough reason to check out the MCRA booth, how about trying your luck on the prize wheel?
As if meeting with us wasn’t a good enough reason to check out the MCRA booth, how about trying your luck on the prize wheel?
Liked by Robert A. Herrmann
-
MCRA is pleased to announce the addition of anesthesia and critical care as a new therapy specialization, led by former FDA Assistant Director Todd…
MCRA is pleased to announce the addition of anesthesia and critical care as a new therapy specialization, led by former FDA Assistant Director Todd…
Liked by Robert A. Herrmann
-
We are pleased to announce the first patient implant of the Nexus™ Aortic Arch Stent Graft System by the surgical team from UH in Northeast Ohio as…
We are pleased to announce the first patient implant of the Nexus™ Aortic Arch Stent Graft System by the surgical team from UH in Northeast Ohio as…
Liked by Robert A. Herrmann
Other similar profiles
-
Devjani Saha
Director, Neurology Regulatory Affairs at MCRA
Connect -
Tim Marjenin
Connect -
Carolyn Yong
Vice President, Regulatory Affairs at MCRA | Former FDA
Connect -
Alex Cadotte
Connect -
Melissa Smallwood
Connect -
Di Lu
Manager, Digital Health Regulatory Affairs | Human Factors and Usability Engineering
Connect -
Michael John
Vice President, Head of Cardiovascular Regulatory Affairs at MCRA Cardio
Connect -
Iris Kim Marklein
Connect -
Robert Hermann
CERTIFIED FINANCIAL PLANNER (TM) with Paquette and Shaw Financial Group LLC
Connect -
Robert Hermann
Software Developer at EVO Payments International
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More